Jackson I T, Callan P P, Forté R A
Institute for Craniofacial and Reconstructive Surgery, Providence Hospital, Southfield, Michigan, USA.
J Craniomaxillofac Surg. 1996 Aug;24(4):230-6. doi: 10.1016/s1010-5182(96)80006-0.
Maxillary ameloblastoma is a different entity from its mandibular counterpart. It is reported to behave more aggressively and have a poorer prognosis. Eleven maxillary ameloblastomas (three recurrent) are reported with a follow-up ranging from 1 month to 12 years with no recurrences. It is proposed that radical treatment of these tumours, with good reconstruction, can give satisfactory function and survival. To that end, the tumours have been classified as to their position in the maxilla and surgical resection related to this.
上颌成釉细胞瘤与其下颌对应物是不同的实体。据报道，其行为更具侵袭性，预后较差。本文报告了11例上颌成釉细胞瘤（3例复发性），随访时间从1个月到12年不等，均无复发。有人提出，对这些肿瘤进行根治性治疗并进行良好的重建，可以获得满意的功能和生存率。为此，根据肿瘤在上颌骨中的位置及其相关手术切除情况对肿瘤进行了分类。
